tirzepatide weight loss percentage Adults with obesity using maintain 'remarkable' at 88 weeks Efficacy and safety of tirzepatide

Gastrointestinal side effects are the most common and include: Nausea (reported in 12% to 29% of patients, depending on dose) Diarrhea (occurring in 13% to 23% of patients) Vomiting (affecting 4% to 9% of patients) Constipation (reported in 6% to 11% of patients) Abdominal pain and dyspepsia (affecting 6% to 9% of patients) Decreased appetite (common and often contributes to weight loss) These gastrointestinal symptoms typically occur during dose escalation and often improve with continued use

Typically not

Pignatelli P et al

True allergic reactions typically involve symptoms beyond the injection site and may include respiratory symptoms, gastrointestinal disturbance, or cardiovascular changes

What is Glutathione and what does it do

Evion LC Tablet is a prescription medicine